NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fermi Inc. ("Fermi" or the "Company") (NASDAQ:FRMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against DeFi Technologies Inc. ("DeFi Technologies" or the "Company") (NASDAQ:DEFT) and certain officers.�� The class action, filed in the United States District Court for the Eastern District of New York, and docketed
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. ("F5" or the "Company") (NASDAQ:FFIV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who
NEW YORK, NY / ACCESS Newswire / January 25, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DoubleVerify Holdings, Inc. ("DoubleVerify" or "the Company") (NYSE:DV). Investors who purchased DoubleVerify securities prior to November 10, 2023, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet Inc. ("Smartsheet" or the "Company") (NYSE:SMAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flywire Corporation ("Flywire" or "the Company") (NASDAQ:FLYW). Investors who purchased Flywire securities prior to February 28, 2025, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charter Communications, Inc. ("Charter" or "the Company") (NASDAQ:CHTR). Investors who purchased Charter securities prior to July 26, 2024, and continue to hold to the present, are encouraged to obtain
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of KBR, Inc. ("KBR" or "the Company") (NYSE:KBR). Investors who purchased KBR securities prior to May 6, 2025, and continue to hold to the present, are encouraged to obtain additional